New Zealand Pharmaceuticals & Biotech Most Popular Stocks

Results

0 new

Most Popular Stocks on the market

4 companies

AFT Pharmaceuticals

Market Cap: NZ$407.9m

Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.

AFT

NZ$3.89

6.3%

42.0%

Pacific Edge

Market Cap: NZ$347.7m

A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.

PEB

NZ$0.28

-6.7%

180.0%

BLIS Technologies

Market Cap: NZ$21.7m

Develops and sells probiotics in New Zealand, the Asia Pacific, Europe, the Middle East, Africa, and North America.

BLT

NZ$0.017

-15.0%

Rua Bioscience

Market Cap: NZ$9.8m

Engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally.

RUA

NZ$0.029

3.6%

11.5%